Selime Aydoğdu

Selime Aydoğdu

Auto-generated profile, based on publicly available information

Selime Aydoğdu

Department of Pediatric Hematology and Oncology University of Health Sciences, Umraniye Training and Research Hospital Istanbul Turkey

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 2021 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
AAAli Önder Atça
Ali Önder Atça
BEBerrin Erok
Berrin Erok
SASelime Aydoğdu
Selime Aydoğdu
Background: Haematopoietic stem cell transplantation (HSCT) is used worldwide in various malignant and nonmalignant childhood diseases, including haematologic, genetic, autoimmune and metabolic disorders, and is the only curative treatment for many of these illnesses. The survival rates of many childhood diseases have been increased due to HSCT treatment. However, associated complications are still important for management. Central nervous system (CNS) complications in paediatric HSCT recipients can be associated with high morbidity and significantly contribute to mortality. Posterior reversible encephalopathy syndrome (PRES) is one of the most common CNS complications in patients with neurological symptoms following HSCT. Magnetic resonance imaging (MRI) is the modality of choice and shows typical bilateral vasogenic oedema at the posterior parts of the cerebral hemispheres; however, various atypical imaging manifestations can also occur. In this study, we retrospectively examined CNS complications in our paediatric HSCT recipients with a focus on the typical and atypical neuroimaging manifestations of PRES following HSCT. Methods: We retrospectively reviewed the medical records of 300 consecutive paediatric HSCT recipients from January 2014 to November 2018. A total of 130 paediatric HSCT recipients who experienced neurological signs and symptoms and were evaluated with neuroimaging studies following HSCT were enrolled in the study. The timing of CNS complications was defined according to immune status, including the pre-engraftment period (< 30 days after HSCT), the early postengraftment period (30–100 days after HSCT), and the late postengraftment period (> 100 days after HSCT), which were defined as phases 1, 2 and 3, respectively. Results: Overall, 130 paediatric HSCT recipients experienced neurological signs and symptoms and therefore underwent neuroimaging examinations. Among these 130 patients, CNS complications were present in 23 patients (17.6%, 23/130), including 13 (56.5%) females and 10 (43.5%) males with a median age of 8.0 years (range, 8 months to 18.0 years). Among these 23 patients, 14 cases of PRES (60.9%), 5 (21.7%) cases of leukoencephalopathy, 3 cases of acute subdural haemorrhage (ASDH) (13%) and 1 (4.3%) case of fungal CNS infection were identified by neuroimaging. On MRI, typical parietooccipital vasogenic oedema was present in 78.5% of the PRES cases (11/14). The following atypical neuroimaging manifestations were observed: isolated involvement of the bilateral frontal lobes in 1 case, isolated cerebellar vermis involvement in 1 case, and isolated basal ganglia involvement in 1 case. Restricted diffusion associated with cytotoxic damage was demonstrated in 2 of 14 cases, one of which also showed subacute cytotoxic injury with ADC pseudonormalization. Conclusion: Paediatric HSCT recipients presenting with CNS signs and symptoms should be evaluated by neuroimaging studies for timely diagnosis and early management. PRES is the most common CNS complication and may present with atypical MRI manifestations, which should not dissuade a PRES diagnosis in appropriate clinical settings.

2 January 2021 in Hemoglobin
Verified
Journal Article
Closed access
SASelime Aydogdu
Selime Aydogdu
ETErsin Toret
Ersin Toret
BABasak A. Aksoy
Basak A. Aksoy
MAMuhammed Fatih Aydın
Muhammed Fatih Aydın
FCFunda Cipe
Funda Cipe
TFTunc Fisgin
Tunc Fisgin
Allogeneic hematopoietic stem cell transplantation (HSCT) is the curative therapy for β-thalassemias that induces severe life-threatening complications. The human leukocyte antigen (HLA) registries and umbilical cord blood banks have carried out diligent searches to find matched unrelated donors (MUDs) for about 70.0% of patients from 2000 onwards. The chance of finding a non-sibling fully matched family donors is higher in some ethnic groups in which consanguineous marriages are common. We have studied and compared transplant complications and outcomes in different graft types (sibling, non-sibling family and unrelated). The non-sibling matched family donor (MFD) group consisted of four mothers, three fathers, five cousins, one paternal uncle and one paternal aunt. There was no significant difference in the mean transfused CD34+ cells, engraftment, median days of neutrophil and platelet recovery were achieved (p > 0.05). The distribution of postttransplant complication did not show any significant difference between groups (p > 0.05). In univariate analysis and multivarite analyses, age, gender, Pesaro risk group (I-II vs. III) and ABO incompatibilty demonstrated a significant difference in disease free survival (p < 0.05). Furthermore, in the second step of investigating overall survival (OS), age, gender and Pesaro risk group (I-II vs. III) showed a significant difference (p < 0.05). There was no significant difference in transplant-related mortality (TRM) between groups. Non-sibling related donor transplants are important for populations where consanguineous marriages are common. Transplant groups according to graft type had similar thalassemia-free survival (TFS) and OS when using a treosulfan-based regimen in our study.

9 October 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
BKBegum Sirin Koc
Begum Sirin Koc
FTFunda Tekkesin
Funda Tekkesin
AAAysenur Kanat Aydin
Aysenur Kanat Aydin
ZBZehragul Balik
Zehragul Balik
Ulku Miray YildirimUlku Miray Yildirim
Ulku Miray Yildirim
SKSUAR ÇAKI KILIÇ
SUAR ÇAKI KILIÇ
Objective: In childhood cancers, parents are affected psychologically as well as children. We aimed to evaluate the effect of childhood cancer type and stage, as well as elapsed time from diagnosis, on the anxiety and stress indicators among parents. Materials and Methods: Patients aged between 0–18 years and diagnosed with cancer who were receiving chemotherapy (0–1 month, 1–6 month, 6–12 month) and completed treatment were included. Parents of those children (mother or father) who agreed to participate this study were also included. The personal information form and three psychological assessment scales (Beck Hopelessness Scale (PSS), Psychological Resilience Scale (PRS), Uncertainty Intolerance Scale (IUS)) were used for assessment of mental health of the parents. Scores of the scales and clinical features of the children with cancer were compared statistically. Results: The study included 84 parents (57 mothers, 27 fathers) and 84 children. The rate of children with solid tumors was 60% (n:50) and 40% of them were metastatic, which means advanced stage. The rate of the children with leukemia was 40% (n:34) and 23% of them were in high-risk group. According to the type (leukemia vs. solid tumors) and stage (high risk/advanced stage vs. others) of the cancer, there was no statistical difference among parents in the psychological scales (p > 0.05). Additionally, results of the psychological scales showed no significant difference between mothers and fathers (p > 0.05). The hopelessness scores are significantly higher among parents whose child’s treatment is terminated compared with those whose active therapy is ongoing, and resilience scores are higher among parents who have less than 1 month since diagnosis of childhood cancer than later periods. Conclusions: The regular assessment of mental health among parents of children with cancer across all the survivorship trajectory: at the time of diagnosis, during active therapy, and after treatment.

1 January 2016 in The Journal of Child
Verified
Journal Article
Closed access
SASelime Aydoğdu
Selime Aydoğdu
SKSerap Karaman
Serap Karaman
ZKZeynep Karakaş
Zeynep Karakaş

1 January 2016 in The Journal of Child
Verified
Journal Article
Closed access
SASelime Aydoğdu
Selime Aydoğdu
AÇAhsen Çelik
Ahsen Çelik
ZKZeynep Karakaş
Zeynep Karakaş

20 December 2019 in Ege Tıp Bilimleri Dergisi
Verified
Journal Article
Open access
PDF file
ETErsin Töret
Ersin Töret
BABaşak ADALI AKSOY
Başak ADALI AKSOY
GÇGözdenur Çavuş
Gözdenur Çavuş
SASelime Aydoğdu
Selime Aydoğdu
FCFunda Cipe
Funda Cipe
CBCeyhun Bozkurt
Ceyhun Bozkurt
Amaç: Hematopoetik kök hücre nakli (HKHN) çocukluk çağının benign ve malign pek çok hastalığı için küratif tedavi seçeneğidir. Hastalara kök hücre infüzyonundan önce uygulanan tedaviler ve hastaların anksiyetesi beslenmelerinin bozulmasına neden olur. Beslenmenin bozulması sonucu gelişen malnütrisyon hastaların yaşam kalitesini ve tedavi başarısına negatif yönde etkiler. Parenteral beslenme güvenli ve etkin bir yöntem olması dolayısıyla tercih edilirken son yıllarda nazogastrik sonda (NGS) ile beslenme, gastrointestinal yolu fonksiyonel tutması ve daha fizyolojik olması nedeniyle ön plana çıkmıştır. Bu araştırmada nakil sürecinde farklı beslenme yöntemleri uygulanan üç grup tedavi sonuçları ve komplikasyonlar açısından karşılaştırılması amaçlanmıştır. Gereç ve Yöntem: İki bin onbeş ile 2019 yılları arasında allojenik HKHN uygulanan 97 olgu beslenme yöntemlerine göre enteral, parenteral ve karışık tip olmak üzere üç gruba ayrıldı. Tüm olguların demografik özellikleri (yaş, cins, tanı), nötrofil ve trombosit engraftman zamanları ve komplikasyon varlığı kayıt altına alındı. Veriler istatiksel yöntemler kullanılarak incelendi. Bulgular: Ortanca nakil yaşları 8.5 yıl (6 ay-17 yıl) olan 97 olguya (55 erkek, 42 kız) allojenik HKHN sırasında 33’üne enteral, 32’sine parenteral ve yine 32’sine karışık tip beslenme uygulandı. Grupların yatış süreleri, ortanca trombosit engraftman zamanları ve mukozit süreleri açısından istatiksel anlamlı fark saptandı. Nakil sonrası komplikasyonlar için değerlendirme yapıldığında akut GvHH (derece I-IV) ve CMV enfeksiyonu açısından gruplar arasında istatiksel anlamlı fark saptandı. Sonuç: Enteral beslenme naklin başarısını olumlu etkisi ve maliyeti etkin bir yöntem olmanın yanı sıra nakil sonrası komplikasyonların azalmasını sağlar.